Intravenous albumin for the prevention of hemodynamic instability during sustained low-efficiency dialysis: a randomized controlled feasibility trial (The SAFER-SLED Study)
Edward G. Clark(University of Ottawa), Swapnil Hiremath(Apple (Israel)), Elham Sabri(Ottawa Hospital), Mark Canney(University of Ottawa), Jennifer Kong(Ottawa Hospital), Pierre-Antoine Brown(University of Ottawa), Gregory L. Hundemer(University of Ottawa), Irene Watpool(Ottawa Hospital), Tim Ramsay(University of Ottawa), Lauralyn McIntyre(Ottawa Hospital Research Institute), Manish M. Sood(Ottawa Hospital)
Cited by 13
Related Papers
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
Age of Transfused Blood in Critically Ill Adults
|New England Journal of Medicine|2015|559